Detalhe da pesquisa
1.
Fe²âº block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²âº influx.
Mol Pharmacol
; 82(6): 1194-204, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973060
2.
Evaluation of a two-site, three-barrier model for permeation in Ca(V)3.1 (alpha1G) T-type calcium channels: Ca (2+), Ba (2+), Mg (2+), and Na (+).
J Membr Biol
; 235(2): 131-43, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20512318
3.
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm.
J Biomol Screen
; 21(1): 1-11, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26170255
4.
Y3+ block demonstrates an intracellular activation gate for the alpha1G T-type Ca2+ channel.
J Gen Physiol
; 124(6): 631-40, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15572343
5.
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac Risk.
Sci Rep
; 5: 17623, 2015 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26616666
6.
Functional Characterization of Human Stem Cell-Derived Cardiomyocytes.
Curr Protoc Pharmacol
; 64: 11.12.1-26, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25152802
7.
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Sci Rep
; 3: 2100, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23812503
8.
Ni2+ block of CaV3.1 (alpha1G) T-type calcium channels.
J Gen Physiol
; 132(2): 239-50, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18663132
9.
Permeation and gating in CaV3.1 (alpha1G) T-type calcium channels effects of Ca2+, Ba2+, Mg2+, and Na+.
J Gen Physiol
; 132(2): 223-38, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18663131
10.
Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5.
J Biol Chem
; 283(11): 6968-78, 2008 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-18184654
11.
The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
J Biol Chem
; 277(7): 4989-98, 2002 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11741928
12.
Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy.
J Lab Clin Med
; 141(2): 121-30, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12577048
13.
The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival.
J Biol Chem
; 279(25): 26280-6, 2004 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15096511
14.
Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy.
J Lab Clin Med
; 142(5): 332-40, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14647037